Mian Xi

2.4k total citations
105 papers, 1.6k citations indexed

About

Mian Xi is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mian Xi has authored 105 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Surgery, 59 papers in Pulmonary and Respiratory Medicine and 35 papers in Oncology. Recurrent topics in Mian Xi's work include Esophageal Cancer Research and Treatment (62 papers), Gastric Cancer Management and Outcomes (34 papers) and Esophageal and GI Pathology (24 papers). Mian Xi is often cited by papers focused on Esophageal Cancer Research and Treatment (62 papers), Gastric Cancer Management and Outcomes (34 papers) and Esophageal and GI Pathology (24 papers). Mian Xi collaborates with scholars based in China, United States and Germany. Mian Xi's co-authors include Lei Zhao, Meng‐Zhong Liu, Shiliang Liu, Mengzhong Liu, Qiao-Qiao Li, Li Zhang, Qiaoqiao Li, Hong Yang, Steven H. Lin and Yong-Hong Hu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Mian Xi

100 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mian Xi

Since Specialization

Citations

This map shows the geographic impact of Mian Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mian Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mian Xi more than expected).

Fields of papers citing papers by Mian Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mian Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mian Xi. The network helps show where Mian Xi may publish in the future.

Co-authorship network of co-authors of Mian Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Mian Xi. A scholar is included among the top collaborators of Mian Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mian Xi. Mian Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Volatile organic compounds in exhaled breath: Applications in cancer diagnosis and predicting treatment efficacy 2025 ·PubMed ·(unknown), Baoqing Chen, Xiaoyu Cheng, (unknown), Qiaoqiao Li, Mian Xi	3
2	Comparison of resection, ablation, and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤5 cm: a retrospective, multicenter, cohort study 2024 ·International Journal of Surgery ·Yizhen Fu, (unknown), Shiliang Liu, Renguo Guan, (unknown), Jinbin Chen, Juncheng Wang, Yangxun Pan, Mengzhong Liu, Minshan Chen, Mian Xi, Yaojun Zhang	4
3	Stereotactic body radiotherapy is an alternative to radiofrequency ablation for single HCC ≤5.0 cm 2024 ·JHEP Reports ·(unknown), Shiliang Liu, Hu Li, Jinbin Chen, Juncheng Wang, Yangxun Pan, Li Xu, Mengzhong Liu, Minshan Chen, Mian Xi, Yaojun Zhang	2
4	Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial 2023 ·Radiation Oncology ·(unknown), (unknown), Baoqing Chen, Mian Xi, Qiaoqiao Li, Yonghong Hu, Yujia Zhu	4
5	Efficacy and cost‐effectiveness analysis of pretreatment percutaneous endoscopic gastrostomy in unresectable locally advanced esophageal cancer patients treated with concurrent chemoradiotherapy (GASTO 1059) 2023 ·Cancer Medicine ·(unknown), (unknown), (unknown), Bo Qiu, Yujia Zhu, Lei Zhao, Mian Xi, (unknown), Suping Guo, JinYu Guo, (unknown), Daquan Wang, (unknown), (unknown), Yonghong Hu, Mengzhong Liu, (unknown), Hui Liu	2
6	Induction chemotherapy plus definitive chemoradiotherapy versus chemoradiotherapy alone in esophageal squamous cell carcinoma: Long-term results and exploratory analyses of a randomized controlled trial. 2023 ·Journal of Clinical Oncology ·Mian Xi, Baoqing Chen, Shiliang Liu, Yujia Zhu, Lei Zhao, Mengzhong Liu	2
7	A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901) 2023 ·EClinicalMedicine ·Rui Chen, Qianwen Liu, Qiaoqiao Li, (unknown), Lei Zhao, Shiliang Liu, Baoqing Chen, Mengzhong Liu, Yonghong Hu, Ting Lin, Jibin Li, Jian‐Zhang Chen, (unknown), Jianhua Fu, Mian Xi, Hong Yang	23
8	Progression‐free survival at 3 years is a reliable surrogate for 5‐year overall survival for patients suffering from locally advanced esophageal squamous cell carcinoma 2022 ·Cancer Medicine ·(unknown), (unknown), Yuzhen Zheng, (unknown), Shiliang Liu, Mian Xi, Meng‐Zhong Liu, Junye Wang, Shunan Qi, Yong Yang, Lei Zhao	7
9	Risk factors and prognosis for esophageal fistula in patients with esophageal squamous cell carcinoma during radiotherapy 2022 ·Esophagus ·(unknown), Chao Zhang, Yuting Wang, Kongjia Luo, (unknown), (unknown), Shiliang Liu, Qiaoqiao Li, Mian Xi	5
10	Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma 2021 ·OncoImmunology ·(unknown), Yu Wang, Qianwen Liu, Yihuai Hu, Jianhua Fu, Xiuying Xie, Shuishen Zhang, Mian Xi, Jing Wen	27
11	Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy 2020 ·Radiotherapy and Oncology ·(unknown), Jinhan Zhu, Jun Zhang, Zhou Sha, (unknown), Zizhen Feng, Li Zhang, Shi Wang, Mian Xi	9
12	Comparative analysis between induction chemotherapy combined with concurrent chemoradiotherapy and chemoradiotherapy alone for thoracic esophageal squamous cell carcinoma 2019 ·Zhonghua fangshe zhongliuxue zazhi ·(unknown), Mian Xi, Shanshan Bu, Gang Xu, Hong Ge	1
13	The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy 2017 ·Radiotherapy and Oncology ·Mian Xi, Cai Xu, Zhongxing Liao, Wayne L. Hofstetter, Mariela Blum Murphy, Dipen M. Maru, Manoop S. Bhutani, Jeffrey H. Lee, Brian Weston, Ritsuko Komaki, Steven H. Lin	47
14	¹⁸F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma 2017 ·Journal of Nuclear Medicine ·Mian Xi, Zhongxing Liao, Wayne L. Hofstetter, Ritsuko Komaki, Linus Ho, Steven H. Lin	15
15	Comparison of two inflammation-based prognostic scores in patients with thoracic esophageal cancer undergoing chemoradiotherapy 2016 ·Peng Zhang, Mian Xi, Lei Zhao, (unknown), Jing Shen, Qing Liu, (unknown)	6
16	P300 promotes migration, invasion and epithelial-mesenchymal transition in a nasopharyngeal carcinoma cell line 2016 ·Oncology Letters ·Zhiwei Liao, Lei Zhao, Muyan Cai, Mian Xi, Liru He, Yu Fang, (unknown), Mengzhong Liu	17
17	Unilateral Cervical Nodal Metastasis Is an Independent Prognostic Factor for Esophageal Squamous Cell Carcinoma Patients Undergoing Chemoradiotherapy: A Retrospective Study 2014 ·PLoS ONE ·Peng Zhang, Mian Xi, Lei Zhao, Qiao-Qiao Li, Liru He, Shiliang Liu, JingXian Shen, Meng‐Zhong Liu	3
18	Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis 2013 ·PLoS ONE ·Mian Xi, Li Zhang, Lei Zhao, Qiao-Qiao Li, (unknown), Zizhen Feng, Xiaowu Deng, (unknown), Meng‐Zhong Liu	110
19	Prognostic Factors and Survival in Patients with Radiation-Related Second Malignant Neoplasms Following Radiotherapy for Nasopharyngeal Carcinoma 2013 ·PLoS ONE ·Mian Xi, (unknown), Lei Zhao, (unknown), Li Zhang, Peng Zhang, (unknown)	11
20	Definition of internal target volume and domestric study for hepatocellular carcinoma using four-dimensional CT 2009 ·Zhonghua fangshe zhongliuxue zazhi ·Mian Xi, Mengzhong Liu, Xiaowu Deng, Li Zhang, Xiaoyan Huang, Ling Cai	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact